EGFR TKI resistance via role VEGFR2

被引：0
|
作者：
Osude, Chike [1 ]
Lin, Leo [1 ]
Puri, Neelu [1 ]
机构：
[1] Univ Illinois, Coll Med, Rockford, IL 61107 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-189
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
189
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Study of properties of VEGFR2 active site and binding mode of VEGFR2 and its inhibitors
    Chen Jun
    Sheng Chun-Quan
    Zheng Can-Hui
    Li Yao-Wu
    Lu Jia-Guo
    Zhang Wan-Nian
    Zhou You-Jun
    Zhu Ju
    ACTA CHIMICA SINICA, 2007, 65 (06) : 547 - 552
  • [22] Gremlin Regulates Tubular Epithelial to Mesenchymal Transition via VEGFR2: Potential Role in Renal Fibrosis
    Marquez-Exposito, Laura
    Lavoz, Carolina
    Rodrigues-Diez, Raul R.
    Rayego-Mateos, Sandra
    Orejudo, Macarena
    Cantero-Navarro, Elena
    Ortiz, Alberto
    Egido, Jesus
    Selgas, Rafael
    Mezzano, Sergio
    Ruiz-Ortega, Marta
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [23] The emerging role of SOX2 in cancer cell plasticity and EGFR-TKI resistance
    Chiu, Yu-Fan
    Kuo, Ming-Han
    Lee, An-Chun
    Chou, Yu-Ting
    CANCER RESEARCH, 2016, 76
  • [24] Sulfated polysaccharide JCS1S2 inhibits angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling
    Wang, Zheng
    Jin, Can
    Li, Xueying
    Ding, Kan
    CARBOHYDRATE POLYMERS, 2019, 207 : 502 - 509
  • [25] Epoxyquinol B shows antiangiogenic and antitumor effects by inhibiting VEGFR2, EGFR, FGFR, and PDGFR
    Kamiyama, Hiroshi
    Kakeya, Hideaki
    Usui, Takeo
    Nishikawa, Kiyohiro
    Shoji, Mitsuru
    Hayashi, Yujiro
    Osada, Hiroyuki
    ONCOLOGY RESEARCH, 2008, 17 (01) : 11 - 21
  • [26] Preclinical Pharmacokinetics and In Vitro Metabolism of BMS-690514, a Potent Inhibitor of EGFR and VEGFR2
    Marathe, Punit
    Tang, Yuwei
    Sleczka, Bogdan
    Rodrigues, David
    Gavai, Ashvinikumar
    Wong, Tai
    Christopher, Lisa
    Zhang, Hongjian
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (08) : 3579 - 3593
  • [27] Inhibition of VEGFR2 and EGFR signaling cooperatively suppresses the proliferation of oral squamous cell carcinoma
    Onda, Maho
    Ota, Akinobu
    Ito, Kunihiro
    Ono, Takayuki
    Karnan, Sivasundaram
    Kato, Mikako
    Kondo, Sayuri
    Furuhashi, Akifumi
    Hayashi, Tomio
    Hosokawa, Yoshitaka
    Kazaoka, Yoshiaki
    CANCER MEDICINE, 2023, 12 (15): : 16416 - 16430
  • [28] Role of Glutathione in the Regulation of VEGFR2 in Human Aortic Endothelial Cells
    Prasai, Priya K.
    Pattillo, Christopher B.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [29] VEGF, VEGFR1, and VEGFR2 expression in melanoma
    Mehnert, J. M.
    McCarthy, M. M.
    Aziz, S. A.
    Sznol, M.
    Flaherty, K. T.
    Camp, R. L.
    Rimm, D. L.
    Kluger, H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] VEGF and VEGFR2 binding to fibronectin
    Usuelli, M.
    Meyer, T.
    Mezzenga, R.
    Mitsi, M.
    FEBS OPEN BIO, 2021, 11 : 82 - 83
12345